Navigation Links
Actavis Full Year 2012 Net Revenue Increases 29% to $5.91 Billion
Date:2/19/2013

shareholders$
28.0$
94.8$
97.3$
260.9Plus:Interest expense54.612.7116.781.8Interest income(1.2)(0.5)(2.5)(2.1)Provision for income taxes88.261.5146.8196.9Depreciation (includes accelerated depreciation)36.821.397.593.6Amortization(1)148.4151.5481.9355.5EBITDA354.8341.3937.7986.6Adjusted for:Global supply chain initiative8.40.214.411.0Acquisition and licensing charges77.814.9294.137.7Non-cash impairment charges29.918.7149.544.3Non-recurring (gains) losses(119.3)(0.9)(134.6)(13.2)Legal settlements27.35.087.75.0Accretion (income) expense-(0.1)0.4(0.3)Share-based compensation14.114.348.739.8Adjusted EBITDA$
393.0$
393.4$
,397.9$
,110.9(1) Includes amortization of excess purchase price on equity method investment.The following table presents a reconciliation of forecasted net income for the twelve months ending December 31, 2013 to non-GAAP net income and non-GAAP earnings per diluted share:

 Table 6Actavis, Inc.Reconciliation Table - Forecasted Non-GAAP Earnings Per Diluted Share(Unaudited; in millions except per share amounts)Forecast for Twelve Months
Ending December 31, 2013LowHighGAAP to Non-GAAP net income calculationGAAP net income$
440$
490Adjusted for:Amortization 625630Global supply chain initiative3535Acquisition and licensing charges 150150Interest accretion on contingent liability 77Non-cash impairment charges Non-recurring (gains) losses Income taxes on items above(222)(224)Adjusted Non-GAAP net income1,0351,088Diluted earnings per shareDiluted earnings per share - GAAP $
3.27$
3.65Diluted earnings per share - Non-GAAP$
7.70$
8.10Diluted weighted average common shares outstanding*134.4134.4*Includes the maximum of 5.5 million shares potentially issuable to the former shareholders of the Actavis Group, subject to final determination of the legacy Actavis business' 2012 Cash EBITDA as calculated in the Actavis acquisit
'/>"/>

SOURCE Actavis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Watson to Acquire Actavis Group for EUR4.25 Billion
2. Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets)
3. Actavis Launches Generic Equivalent of Adalat® CC 90mg (Nifedipine Extended-Release Tablets, USP)
4. Watson and Actavis Receive FTC Second Request
5. Watson Announces New Name -- Actavis -- for Global Operations
6. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
7. Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
8. Actavis, Inc. to Present at the RBC Capital Markets Healthcare Conference
9. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
10. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
11. Aethlon Medical Note: Fiscal Year Revenue Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014  Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ... by its indirect wholly-owned subsidiary, Sapphire Subsidiary Corp. ("Purchaser"), ... of Solta Medical, Inc. (NASDAQ: SLTM ) ...
(Date:1/15/2014)... 2014  Zafgen, Inc., a leading biopharmaceutical company dedicated ... patients, today announced initial results from its Phase ... methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi ...  These results showed improvements in body weight, hunger-related ...
(Date:1/14/2014)... AUSTIN, Texas , Jan. 14, 2014  Luminex Corporation (Nasdaq: ... report results for the fourth quarter of 2013 on Monday, ... scheduled for release after the close of trading. ... a conference call to discuss the operating highlights and financial ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3
... 2011 Phreesia, the patient check-in company, today ... health records (EHR) software and solutions, has been ... partnership, medical practices nationwide that use both SOAPware ... seamless patient check-in experience. The automated interface between ...
... 18, 2011 Ohio-based AdCare Health Systems, Inc. ... Remedi SeniorCare®, one of the nation,s largest institutional ... services for AdCare,s facilities  that deliver long-term care ... Remedi pharmacy services will include pharmacist ...
Cached Medicine Technology:Phreesia and SOAPware Integrate to Improve Clinical Data and Streamline Workflow at Medical Practices 2Phreesia and SOAPware Integrate to Improve Clinical Data and Streamline Workflow at Medical Practices 3AdCare Health Systems Selects Remedi SeniorCare for Long-Term Care Pharmacy Solutions 2AdCare Health Systems Selects Remedi SeniorCare for Long-Term Care Pharmacy Solutions 3
(Date:4/22/2014)... is the standard measurement for assessing glycemic control over ... are typically measured every few months in a laboratory, ... accurately estimates A1c using self-monitored blood glucose (SMBG) readings, ... ( DTT ), a peer-reviewed journal from Mary Ann ... the DTT website at http://www.liebertpub.com/dtt . ...
(Date:4/22/2014)... rein in massive health care spending, a new RAND ... ways to incentivize pharmaceutical companies and device makers to ... examining existing medical technologies and their use, a new ... drugs and medical devices get created in the first ... spending with as little loss of health as possible ...
(Date:4/22/2014)... Nearly 7 in 10 Americans support mandated coverage ... survey by researchers at the University of Michigan Health ... the age of 18 at home, and adults with ... other adults to support universal coverage of birth control ... Journal of the American Medical Association ( ...
(Date:4/22/2014)... is available in German . ... of the University of Vienna and the Medical University of ... shown how double stranded RNA, such as viral genetic information, ... the immune response against viral infection, the protein ADAR1 moves ... modifies viral RNA to inhibit reproduction of the virus. But ...
(Date:4/22/2014)... Washington, DC -- When mothers are exposed to trauma, ... activate a single molecular trigger in brain cells that ... post-traumatic stress disorder and some forms of autism. , ... stressors have impacted the cells of a developing brain. ... exposes herself to alcohol or drug abuse or she ...
Breaking Medicine News(10 mins):Health News:US medical innovation needs smarter incentives to cut health spending, study finds 2Health News:US medical innovation needs smarter incentives to cut health spending, study finds 3Health News:More than two-thirds of Americans support mandated coverage of birth control in health plans 2Health News:How the body fights against viruses 2Health News:How the body fights against viruses 3Health News:Life stressors trigger neurological disorders, researchers find 2
... , ... named Capital Confirmation, Inc. its 2010 Best in Business winner for the 1 – 25 ... ... provider of secure audit confirmation services, was named “Best in Business” in the 1 – ...
... ... report assessing best pharmaceutical value-added programs and account managers among key managed care ... ... an ongoing market research project that provides strategic and tactical information to assist ...
... variations might reveal women most at risk, researchers say , ... expression of two common genes trigger cellular changes that can ... researchers adjusted the expression of the genes -- estrogen receptor ... they made in the rodents likely mimic natural variations of ...
... Hundreds ... HCG and how can it help us? , ... May 13, 2010 -- HCG, or human chorionic gonadotropin, is a natural hormone that is found in ... as energy for both the mom and her developing baby. , , , , ,Now, thanks ...
... Non surgical ... ... (GLI) announced a revolutionary hair replication solution recently at their Edina, Mn, office. They utilize ... available. It restores the permanent look of a full head of hair in one day ...
... ... of IT consulting, with many companies providing a variety of high tech services nationwide. ... to offer a spectrum of services to commercial, academic, and governmental IT organizations. , ... South Plainfield, N.J. May 12, 2010 ...
Cached Medicine News:Health News:Capital Confirmation Named Best In Business by Nashville Business Journal 2Health News:Capital Confirmation Named Best In Business by Nashville Business Journal 3Health News:HIRC Research Alert: New Study Identifies Best Pharmaceutical Company Account Managers and Program Offerings 2Health News:HIRC Research Alert: New Study Identifies Best Pharmaceutical Company Account Managers and Program Offerings 3Health News:Small Changes in Two Genes May Trigger Breast Cancer 2Health News:All About the HCG Drops Diet Program—What it is and Why it Works 2Health News:Good Look Ink Announces Revolutionary Hair Replication Solution 2Health News:Astir IT Solutions Inc. Acquires Inothink Solutions 2
Inquire...
Use the Mo Bio Vortex adapter to process multiple samples at the same time. The adapter holds tubes horizontally to increase cell lysis and mixing efficiency. Ideal for bead beating procedures....
Use the Mo Bio Vortex adapter to process multiple samples at the same time. The adapter holds tubes horizontally to increase cell lysis and mixing efficiency. Ideal for bead beating procedures....
... Mo Bio Vortex Adapter in conjunction with the ... Using the Mo Bio Vortex Adapter is ... Fast Prep machines which offer the same technology. ... centrifuge tubes at one time and will fit ...
Medicine Products: